Literature DB >> 9042923

Hereditary spastic paraplegia: LOD-score considerations for confirmation of linkage in a heterogeneous trait.

M P Dubé1, M A Mlodzienski, Z Kibar, M R Farlow, G Ebers, P Harper, E H Kolodny, G A Rouleau, D A Figlewicz.   

Abstract

Hereditary spastic paraplegia (HSP) is a degenerative disorder of the motor system, defined by progressive weakness and spasticity of the lower limbs. HSP may be inherited as an autosomal dominant (AD), autosomal recessive, or an X-linked trait. AD HSP is genetically heterogeneous, and three loci have been identified so far: SPG3 maps to chromosome 14q, SPG4 to 2p, and SPG4a to 15q. We have undertaken linkage analysis with 21 uncomplicated AD families to the three AD HSP loci. We report significant linkage for three of our families to the SPG4 locus and exclude several families by multipoint linkage. We used linkage information from several different research teams to evaluate the statistical probability of linkage to the SPG4 locus for uncomplicated AD HSP families and established the critical LOD-score value necessary for confirmation of linkage to the SPG4 locus from Bayesian statistics. In addition, we calculated the empirical P-values for the LOD scores obtained with all families with computer simulation methods. Power to detect significant linkage, as well as type I error probabilities, were evaluated. This combined analytical approach permitted conclusive linkage analyses on small to medium-size families, under the restrictions of genetic heterogeneity.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9042923      PMCID: PMC1712512     

Source DB:  PubMed          Journal:  Am J Hum Genet        ISSN: 0002-9297            Impact factor:   11.025


  16 in total

1.  Autosomal dominant familial spastic paraplegia is genetically heterogeneous and one locus maps to chromosome 14q.

Authors:  J Hazan; C Lamy; J Melki; A Munnich; J de Recondo; J Weissenbach
Journal:  Nat Genet       Date:  1993-10       Impact factor: 38.330

2.  Faster sequential genetic linkage computations.

Authors:  R W Cottingham; R M Idury; A A Schäffer
Journal:  Am J Hum Genet       Date:  1993-07       Impact factor: 11.025

Review 3.  Hereditary spastic paraplegias.

Authors:  A E Harding
Journal:  Semin Neurol       Date:  1993-12       Impact factor: 3.420

4.  Avoiding recomputation in linkage analysis.

Authors:  A A Schäffer; S K Gupta; K Shriram; R W Cottingham
Journal:  Hum Hered       Date:  1994 Jul-Aug       Impact factor: 0.444

5.  Easy calculations of lod scores and genetic risks on small computers.

Authors:  G M Lathrop; J M Lalouel
Journal:  Am J Hum Genet       Date:  1984-03       Impact factor: 11.025

Review 6.  Hereditary spastic paraplegia: advances in genetic research. Hereditary Spastic Paraplegia Working group.

Authors:  J K Fink; T Heiman-Patterson; T Bird; F Cambi; M P Dubé; D A Figlewicz; J K Fink; J L Haines; T Heiman-Patterson; A Hentati; M A Pericak-Vance; W Raskind; G A Rouleau; T Siddique
Journal:  Neurology       Date:  1996-06       Impact factor: 9.910

7.  Computer-simulation methods in human linkage analysis.

Authors:  J Ott
Journal:  Proc Natl Acad Sci U S A       Date:  1989-06       Impact factor: 11.205

8.  X-linked spastic paraplegia (SPG1), MASA syndrome and X-linked hydrocephalus result from mutations in the L1 gene.

Authors:  M Jouet; A Rosenthal; G Armstrong; J MacFarlane; R Stevenson; J Paterson; A Metzenberg; V Ionasescu; K Temple; S Kenwrick
Journal:  Nat Genet       Date:  1994-07       Impact factor: 38.330

9.  X-linked spastic paraplegia and Pelizaeus-Merzbacher disease are allelic disorders at the proteolipid protein locus.

Authors:  P Saugier-Veber; A Munnich; D Bonneau; J M Rozet; M Le Merrer; R Gil; O Boespflug-Tanguy
Journal:  Nat Genet       Date:  1994-03       Impact factor: 38.330

10.  Construction of human linkage maps: likelihood calculations for multilocus linkage analysis.

Authors:  G M Lathrop; J M Lalouel; R L White
Journal:  Genet Epidemiol       Date:  1986       Impact factor: 2.135

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.